Sponsor or institution

Clinical trials and research at Hangzhou GluBio Pharmaceutical Co., Ltd.

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Evaluating GLB-001 for patients with myeloid malignancies

  This study is testing a new oral treatment called GLB-001 to see if it is safe and effective for people with certain types of blood cancers that have come back or didn't respond to other treatments.

  Recruiting at 14 sites Phase 1 Hangzhou GluBio Pharmaceutical Co., Ltd. · Hefei, Anhui and 13 other locations · NCT06378437

• Testing GLB-002 for patients with relapsed or refractory Non-Hodgkin Lymphomas

  This study is testing a new treatment called GLB-002 to see if it can help people with Non-Hodgkin lymphoma who haven't had success with other therapies.

  Recruiting at 13 sites Phase 1 Hangzhou GluBio Pharmaceutical Co., Ltd. · Beijing, Beijing Municipality and 12 other locations · NCT06219356

Quick answers

How many clinical trials run by Hangzhou GluBio Pharmaceutical Co., Ltd. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →